COST OF ILLNESS PADA PASIEN DIABETES MELITUS TIPE 2 DENGAN MONOTERAPI METFORMIN DI BEBERAPA PUSKESMAS WILAYAH SURABAYA
This study aimed to determine the cost of illness in type 2 diabetes mellitus patients with metformin monotherapy at several primary health care centres in Surabaya. This study was conducted in 10 primary health care centres in Surabaya on January-March 2019. Those primary health care centres we...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses and Dissertations NonPeerReviewed |
| Language: | Indonesian Indonesian Indonesian Indonesian |
| Published: |
2019
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/87786/1/KKB%20KK-2%20FF.Kom.15-19%20Nur%20c%20ABSTRAK.pdf http://repository.unair.ac.id/87786/2/KKB%20KK-2%20FF.Kom.15-19%20Nur%20c%20DAFTAR%20ISI.pdf http://repository.unair.ac.id/87786/3/KKB%20KK-2%20FF.Kom.15-19%20Nur%20c%20DAFTAR%20PUSTAKA.pdf http://repository.unair.ac.id/87786/4/KKB%20KK-2%20FF.Kom.15-19%20Nur%20c%20SKRIPSI.pdf http://repository.unair.ac.id/87786/ http://lib.unair.ac.id |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | Indonesian Indonesian Indonesian Indonesian |
| Summary: | This study aimed to determine the cost of illness in type 2 diabetes
mellitus patients with metformin monotherapy at several primary health
care centres in Surabaya. This study was conducted in 10 primary health
care centres in Surabaya on January-March 2019. Those primary health
care centres were selected based on the highest number of diabetes mellitus
patients at the primary health care centres in Surabaya. This study was a
cross sectional study using purposive sampling. This study was performed
from a societal perspective. The cost measurement method used a list of
interview questions to determine the cost. This study was conducted on 53
patients.
Result showed that the direct medical costs was Rp455,162.47 ±
91,486.69 per patient per year; direct non-medical costs was Rp344,106.37
± 120,350.30 per patient per year; and indirect costs was Rp338,193.00 ±
169,991.80 per patient per year. The biggest cost for the treatment of type
2 diabetes mellitus with metformin monotherapy was direct medical cost
which was drug cost of Rp213,653.03 ± 853,971.93 per patient per year.
The conclusion was the total annual costs of type 2 diabetes mellitus
patients with metformin monotherapy was Rp1,137,461.86 ± 105,437.97
per patient. This research can be used to consider making policies. |
|---|